Navigation Links
Human Genome Sciences Announces First Quarter 2008 Financial Results and Key Developments
Date:5/5/2008

The Company also announced plans to initiate its third randomized chemotherapy combination trial of HGS-ETR1 by mid-2008 in patients with hepatocellular cancer, which accounts for 80-90% of all liver cancers. Preclinical data that support the hepatocellular cancer study were presented at the American Association for Cancer Research annual meeting in April.

Darapladib Advanced by GSK to Phase 3 Development as a Potential Treatment for Atherosclerosis

In its first quarter financial results press release on April 23, 2008, GSK announced that it intends to advance darapladib to Phase 3 clinical trials as a potential treatment for atherosclerosis and will shortly start discussions with regulators regarding the structure of the darapladib Phase 3 program.

At the American College of Cardiology's 57th Annual Scientific Session in March, GSK presented data from a randomized Phase 2 dose-ranging trial of darapladib in patients with coronary heart disease (CHD). The study showed that darapladib produced sustained, dose-dependent inhibition of plasma lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in patients receiving intensive atorvastatin (cholesterol-lowering) therapy. Lp-PLA2 is an enzyme associated with the formation of atherosclerotic plaques and identified in clinical trials as an independent risk factor for CHD and ischemic stroke. Changes in biomarkers suggested a possible reduction in systemic inflammatory burden. In addition, GSK stated in February 2008 that the results of its randomized Phase 2/3 imaging trial of darapladib in coronary artery disease have been submitted to a major medical journal.

Darapladib, a small-molecule inhibitor of Lp-PLA2, was discovered by GSK based on HGS technology. HGS will receive a 10% royalty on worldwide sales of darapladib if it is commercialized, and also has a co-promotion option in North America and Europe under which it will pay 20% of commercialization costs in exchange for 20% of dara
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Pioneer(R) Surgical Technology Announces First Human Implants of its NuNec(TM) Cervical Arthroplasty Device
2. China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex
3. Human Genome Sciences to Sponsor Conference Call to Discuss First Quarter 2008 Financial Results
4. Identity Sciences Introduces a New, Fast Forensic Human I.D. Test
5. Human Genome Sciences Advances Oncology Portfolio
6. AMDL Signs Exclusive Licensing Agreement for Human Papilloma Virus Diagnostic Test Kit in Certain Asian Countries
7. Human Pheromone Sciences Announces Quarterly and Full Year Results
8. CryoLife Announces Implant of First FDA-Cleared SynerGraft(R) Processed Human Pulmonary Heart Valve
9. Oregon Health Care Quality Corporation Receives Important Designation from U.S. Department of Health and Human Services
10. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Cowen Conference
11. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Lehman Brothers Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... 2014  ViveBio, LLC a leading provider of ... transportation, announced today that it has signed a ... of Knoxville, Tennessee to ... the United States . ViveST is the ... dried biological specimen transport systems.  The technology enables ...
(Date:8/26/2014)... (PRWEB) August 26, 2014 The global ... 8,020.1 million by 2020, according to a new study ... medicine and theranostics, and the subsequent introduction of advanced ... driving market growth over the next six years. Moreover, ... diseases such as cancer, coupled with disease triggering lifestyle ...
(Date:8/26/2014)... Trovagene, Inc. (NASDAQ:  TROV) presented data ... Assays to the Clinic with an oral ... Free Tumor DNA in Urine." In this presentation ... Cancer Monitoring (PCM) platform and results from several ... of tumor DNA mutations from urine samples of ...
(Date:8/26/2014)... YORK , Aug. 26, 2014  That,s Nice ... science markets, today announced the formation of a new ... content development. The expanded team will combine current and ... areas at That,s Nice. Guy ... Content to lead the team. Tiene was previously Director ...
Breaking Biology Technology:ViveBio and Laboratory Procurement Services Sign Agreement for Distribution of the ViveST Line of Products 2World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 2World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 3World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 4World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 5World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 6Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4That's Nice Announces Expanded Offering For Strategic Content And Public Relations 2That's Nice Announces Expanded Offering For Strategic Content And Public Relations 3
... Behring, a world leader in the development of plasma-derived and ... CSL Behring – Prof. Heimburger Award 2011 . The ... this year,s theme to " Be Inspired, Get Involved in ... – Prof. Heimburger Award has been inspiring young medical ...
... SAN DIEGO, April 14, 2011 Promising new devices ... or heart failure, and related research, will be revealed ... Lung Transplantation (ISHLT) 31st Annual Meeting and Scientific Sessions. ... Neonates (PumpKIN) Program will be presented during the Meeting ...
... WORTH, Texas, April 14, 2011 The Wound Institute ... on dynamic reciprocity at the combined meeting of the ... Healing Society (WHS) being held in Dallas at the ... 2011. Presenting faculty are Dr. Ira M. Herman, tenured ...
Cached Biology Technology:CSL Behring Marks World Hemophilia Day by Announcing the Winners of the 'CSL Behring - Prof. Heimburger Award 2011' 2CSL Behring Marks World Hemophilia Day by Announcing the Winners of the 'CSL Behring - Prof. Heimburger Award 2011' 3CSL Behring Marks World Hemophilia Day by Announcing the Winners of the 'CSL Behring - Prof. Heimburger Award 2011' 4Progress in the Development of Mechanical Circulatory Support Devices for Children to be Presented at International Heart and Lung Transplant Meeting 2Progress in the Development of Mechanical Circulatory Support Devices for Children to be Presented at International Heart and Lung Transplant Meeting 3The Wound Institute® to Feature Educational Forum on Dynamic Reciprocity During the Symposium on Advanced Wound Care and the Wound Healing Society Annual Meeting 2The Wound Institute® to Feature Educational Forum on Dynamic Reciprocity During the Symposium on Advanced Wound Care and the Wound Healing Society Annual Meeting 3The Wound Institute® to Feature Educational Forum on Dynamic Reciprocity During the Symposium on Advanced Wound Care and the Wound Healing Society Annual Meeting 4
(Date:8/25/2014)... battery-powered DNA diagnostic device invented at New Zealand,s ... commonly used field tool for rapidly detecting suspected ... the level of infection. , The breakthrough device, ... Queenstown Molecular Biology main meeting. It takes advantage ... target DNA sequences in real-time, without the need ...
(Date:8/25/2014)... of proteins that promotes virus entry into cells also ... and other viruses, University of Missouri researchers have found. ... insights into our understanding of not only HIV infection, ... Shan-Lu Liu, M.D., Ph.D., associate professor in the MU ... , The study was recently published in the ...
(Date:8/25/2014)... gentle and efficient cell separation from a device the ... to tilt-angle standing surface acoustic waves, according to a ... to do cell separation before analysis," said Tony Jun ... the separation process affects the integrity of the cells, ... work well.", Tilted-angle standing surface acoustic waves can separate ...
Breaking Biology News(10 mins):Revolutionary handheld DNA diagnostic unit allows lab-quality analysis in the field 2MU researchers discover protein's ability to inhibit HIV release 2MU researchers discover protein's ability to inhibit HIV release 3Tilted acoustic tweezers separate cells gently 2
... 25, 2013   GenoVive , an innovator in personalized ... emerging "globesity" epidemic through its development of a state ... individual,s unique metabolism.  "Weight Loss Designed by Science" has ... an all natural meal and exercise program to assist ...
... After helping the US develop the atomic bomb, Niels ... was freely accessible. His thoughts remain highly relevant in ... of drones and space weapons in warfare raise questions ... consequences of technology. As part of the celebrations ...
... announced the release of a comprehensive, quality-controlled dataset that ... data on the massive Deepwater Horizon Oil Spill. The dataset, ... of dispersants, wraps up a three year process that began ... in the Gulf of Mexico during and after the oil ...
Cached Biology News:"GenoVive is changing the face of personalized health by continuing research efforts with Harvard." 2International Niels Bohr Conference: An open world 2NOAA launches website holding millions of chemical analyses from Deepwater Horizon oil spill 2
... the value of your microarray data using ... you need from consultation to extensive data ... methods. Utilize our expertise in combination with ... your own microarray experiments., ,Normalization and basic ...
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. Material: ...
BD Falcon 850 cm Smooth-surface TufRol Roller Bottle, tissue-culture treated polystyrene, blow-molded one-piece design, with easy on/off non-vented cap, packed in double bag. (20/ca) Packaging: ...
... of Flight Mass Analyzer for superior sensitivity, mass accuracy, and resolving ... m/z, * Precursor ion selection range: 150 - 4000 m/z, * ... with internal reference, * Dynamic range: 4 orders of magnitude ... ...
Biology Products: